Objective To examine whether neonatal seizures are associated with neurodevelopmental outcomes in infants with hypoxia-ischemia independent of the presence and severity of brain injury seen on magnetic resonance imaging (MRI).
S
eizures in the newborn frequently signal an underlying brain disorder, such as hypoxic-ischemic injury, stroke, intracranial infection, or hypoglycemia. 1, 2 Neonates with seizures are at high risk for mortality, and survivors commonly have adverse neurodevelopmental outcomes. [3] [4] [5] [6] Do seizures themselves damage the developing brain, or are they merely a sign of the underlying brain disorder? This is an important and controversial question for neonatal medicine and neurology alike. Clinical management of neonatal seizures has remained unchanged for more than a generation, despite almost 10 years of evidence that phenobarbital-the most commonly used first line antiseizure agent in newborns-has limited efficacy 7 and is potentially neurotoxic in animal models. 8 Insight into whether seizures cause injury to the immature human brain has important implications for guiding clinical care and for determining appropriate outcome measures for clinical trials of antiseizure therapy in the newborn.
Accumulating animal evidence indicates that seizures in the neonatal period can alter brain development and lead to longterm deficits in learning, memory, and behavior. [9] [10] [11] In humans, there is no good evidence that seizures themselves affect neurodevelopmental outcome, however 2 studies using proton and phosphorous magnetic resonance spectroscopy suggest that seizure severity in infants with perinatal asphyxia is associated with brain injury and impaired metabolism independent of the severity of hypoxic-ischemic brain injury. 12, 13 The overlapping adverse effects of hypoxic-ischemic brain injury and early postinjury seizures have hindered determination of the independent neurodevelopmental consequences of neonatal seizures in humans. In the present study, we used a prospective cohort of term infants at risk for hypoxic-ischemic brain damage studied with high-resolution magnetic resonance imaging (MRI), a sensitive measure of the severity of hypoxic-ischemic brain injury in newborns, to assess the independent association between clinical seizures in the newborn period treated in accordance with local standards of care and longterm neurodevelopmental outcome.
Methods
Infants were eligible for inclusion if they were $ 36 weeks gestational age at birth and had any one of the following: umbilical cord artery or first blood gas pH < 7.1, umbilical cord artery or first blood gas base deficit >10, or 5-minute Apgar score # 5. These broad inclusion criteria were chosen to encompass newborns with a wide range of injuries and neurodevelopmental outcomes and have been used in previous reports by our group. 6, 12, [14] [15] [16] [17] [18] Infants with suspected or confirmed congenital malformation, inborn error of metabolism, or congenital infection were excluded. The University of California San Francisco's Committee on Human Research approved the study protocol. An infant was studied only after informed voluntary parental consent was obtained.
Clinical Data
Trained neonatal research nurses prospectively extracted clinical data from maternal and infant records. The severity of encephalopathy was evaluated daily over the first 3 days using the Encephalopathy Score, which ranges from 0 to 6 and is based on physician assessment of alertness, feeding, tone, respiratory status, reflexes, and clinical seizures. 6 Each newborn was prospectively assigned a composite seizure score using a chart review of nursing and physician progress notes and neurophysiology and hospital discharge summaries. This score, developed before study commencement, is heavily weighted toward clinical detection of seizures, reflecting the standard of care at the time of enrollment and the data available for this study. The total score ranges from 0 to 10 and includes scores for seizure frequency (1 point for more than 1 seizure, 2 points for status epilepticus), timing of onset (1 point for onset < 24 hours of life), anticonvulsant therapy (1 point for 1 or 2 medications, 2 points for $ 3 medications, 3 points for barbiturate coma), and neonatal electroencephalography (EEG) abnormalities (1 point for abnormal background without epileptiform discharges, 2 points for abnormal background with epileptiform discharges, 3 points for electrographic seizures, and 4 points for status epilepticus). 12 Here status epilepticus is defined as continuous seizures or multiple seizures without return to normal level of consciousness lasting longer than 20 minutes. EEG background is included in the score because of its known relationship to seizure risk. 19 At the time of hospital discharge, the total score was determined by adding together the highest score in each category. Because seizures are most severe early in the course of hypoxic-ischemic brain injury, the score is not affected by the duration of the patient's hospital admission. At the time of study enrollment, our center did not perform routine prolonged continuous video EEG or amplitude-integrated EEG. The composite seizure scores were subdivided into 3 seizure severity categories (0, no seizures; 1 to 3, mild/moderate seizures; and $ 4, severe seizures).
The infants were treated according to local standard of care, with phenobarbital as the first-line agent and phenytoin or lorazepam as add-on agents as needed. The children in this cohort were studied prior to implementation of therapeutic hypothermia at our center.
Magnetic Resonance Imaging
MRI was performed at a mean (AE standard deviation [SD]) of 5.4 AE 3.0 days using a specialized neonatal head coil on a 1.5-Tesla Signa EchoSpeed system (GE Medical Systems, Milwaukee, Wisconsin). Imaging sequences were optimized for the neonatal brain and included 4-mm (1-mm ''gap'') sagittal spin-echo (SE) images (500/11/2 [TR/TE/excitations]), 4-mm (1-mm gap) axial SE images (500/11/2), and 4-mm (2-mm gap) axial SE images (3000/60,120/1) through the entire brain. The timing of imaging did not differ between the seizure groups (P = .2).
Severity of brain injury was measured using conventional T1-weighted (short-echo) and T2-weighted (long-echo) MRI. Previous work has demonstrated that this provides accurate measurements of brain injury for this age group. Diffusion-weighted imaging was not available during the early part of the study period and thus was not used for this analysis. A pediatric neuroradiologist who was blinded to the clinical history prospectively evaluated the MRI images. Injury to the basal nuclei and the watershed areas was scored independently using a system that is strongly predictive of neurodevelopmental outcome after neonatal encephalopathy. 14 The severity of the basal nuclei pattern of injury, which primarily evaluates deep gray matter and motor pathway injury, was scored as follows: 0, normal or isolated cortical infarct; 1, abnormal signal in the thalamus; 2, abnormal signal in the thalamus and lentiform nucleus; 3, abnormal signal in the thalamus, lentiform nucleus, and perirolandic cortex; or 4, more extensive involvement. The severity of the watershed pattern injury, which evaluates cortical and white matter injury, was scored as 0, normal; 1, single focal abnormality; 2, abnormal signal in anterior or posterior watershed white matter; 3, abnormal signal in anterior or posterior watershed cortex and white matter; 4, abnormal signal in both anterior and posterior watershed zones; or 5, more extensive cortical involvement. The pattern of injury was described as ''basal nuclei-predominant,'' ''watershed-predominant,'' or ''normal.'' 16 Neurodevelopmental Follow-Up A developmental psychologist with experience in examining children with developmental impairment and who was blinded to the neonatal course examined the children at age 4 years using the Wechsler Preschool and Primary Scale of Intelligence-Revised (WPPSI-R). 20 The WPPSI-R provides a fullscale intelligence quotient (FSIQ) with a mean of 100 (SD AE 15), as well as domain scores for Verbal and Performance IQs.
The 5-point neuromotor score was assigned by a neurologist (also blinded to the neonatal course), as described in our previous studies. 17 Children with a score $ 2 have an abnormal neuromotor examination, and those with a score $ 3 have a functional deficit (eg, cerebral palsy).
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Statistics Statistical analyses were performed using Stata 9.2 software (Stata Corp, College Station, Texas). Differences between clinical predictors were assessed using the 2-tailed Student t-test for continuous variables, the median or Wilcoxon rank-sum test for nonparametric data, and the c 2 or Fisher exact for categorical variables. Linear and logistic regression analyses were used to evaluate the association between seizure severity and neurodevelopmental outcome. The adjusted analysis accounted for the severity of hypoxic-ischemic brain injury measured on MRI by including both the maximal watershed and basal nuclei scores, each as a categorical predictor in a multivariate regression. Two sensitivity analyses were performed, one to assess the impact the effect of death within the cohort by imputing the lowest neurodevelopmental scores for children who died before evaluation and the other to account for the fact that diffusion-weighted imaging was not included in this analysis.
Results
A total of 143 infants were enrolled and imaged between November 1996 and June 2003. Of these, 16 died and 77 (61% of the survivors) had a complete neurodevelopmental evaluation at age 4 years. There was no statistical difference in demographic or clinical data between those who had a complete neurodevelopmental evaluation at age 4 years and those lost to follow-up, including sex, birth weight, and encephalopathy score (P > .1). Furthermore, the surviving children who had a complete evaluation at age 4 years were no more likely than those lost to follow-up to have neonatal seizures (32% vs 38%; P = .4) or brain injury detected on MRI (73% vs 72%; P = .9).
The 16 children who died represented the severe spectrum of hypoxic-ischemic brain injury. Nine of these children (56%) had maximal basal nuclei and watershed scores. All 16 had seizures (12 with severe seizures). Eleven (69%) died in the neonatal period after discontinuation of active cardiorespiratory support in the intensive care nursery.
Of the 77 surviving children followed to age 4 years, 11 (14.3%) had severe neonatal seizures (composite seizure score $ 4), 14 (18.2%) had mild/moderate seizures (seizure score 1 to 3), and 52 (67.5%) had no seizures (seizure score 0). All of the 25 infants with seizures had clinical onset before the third day of life (with the exception of a single infant who was paralyzed until day 4 of life for extracorporeal membrane oxygenation). Two infants (8%) required 3 or more antiseizure medications. All of the infants with clinical seizure underwent EEG, which was abnormal in 14 (56%). Recurrent electrographic seizures were detected in 6 cases. Of the infants without clinical seizures, only 1 underwent EEG, which was normal.
There were no significant differences in birth weight or umbilical cord or first arterial blood gas pH or base excess between the infants with severe or mild/moderate neonatal seizures and those without seizures. There was no apparent difference in the percentage of male infants with seizures compared with those without seizures (64% vs 50%; P = .25). The higher rate of seizures in infants born outside our center was not significant. The lower Apgar scores in infants with seizures also were not significant. Infants with neonatal seizures were more likely to have a higher encephalopathy score (P = .002) ( Table I) .
The MRI pattern of hypoxic-ischemic injury differed in infants with severe seizures and those with mild/moderate or no seizures (P < .0001) ( Table II) . The basal nuclei-predominant pattern was most common in the infants with severe seizures (54.6%). The watershed pattern was most common in those with mild/moderate seizures (50.0%). The infants without seizures were more likely to have the watershed pattern of injury (55.8%). Four infants (2 with mild/moderate seizures and 2 with severe seizures) had maximal basal nuclei and watershed scores.
Of the known predictors of outcome, the severity of hypoxic-ischemic brain injury detected by MRI and as measured by our scoring system was most highly associated with cognitive outcome in this cohort. The basal nuclei and watershed scores predicted 39% of the variation in the FSIQ scores, compared with 25% for the maximal encephalopathy score and 29% for the seizure score (all P < .0001).
Unadjusted Analysis
Newborns with seizures in the setting of perinatal asphyxia had worse outcomes than those without seizures (Table  III) . In the unadjusted analysis, for each 1-point increase in seizure score, there was a corresponding 6.1-point decrease in the FSIQ score (95% confidence interval [CI] = -8.3 to -3.9). The infants with documented recurrent seizures on EEG had lower FSIQ scores (mean, 52 vs 95; P < .0001). When seizures were analyzed as a categorical variable, compared with the infants without seizures, those with severe seizures had an average 35.5-point lower FSIQ score (95% CI = -48.8 to -22.1 points), and those with mild/moderate seizures had a 17-point lower FSIQ score (95% CI = -30 to -5). In the unadjusted analysis, the impact of seizures on the WPPSI-R Performance and Verbal IQ scores was similar to that on the FSIQ. Children with neonatal seizures were more likely to have an abnormal neurologic examination (neuromotor score $ 2) at age 4 years compared with those without seizures (unadjusted odds ratio = 20.8; 95% CI = 5.1 to 85.0). Neurologic examination findings were abnormal in 7 children (63.6%) with severe neonatal seizures, 7 (50.0%) with mild/moderate seizures, and 3 (5.8%) without seizures.
Adjusted Analysis
The association between seizures and poor neurodevelopmental outcome persisted after adjusting for the severity of hypoxic-ischemic brain injury as measured by the basal nuclei and watershed scores on MRI (Table III) . In the adjusted analysis, for each 1-point increase in seizure score, there was a corresponding 4.7-point decrease in the FSIQ score (95% CI = -7.2 to -2.2). The effect of documented recurrent seizures on EEG also persisted after adjusting for injury on MRI, with an average 33.0-point lower FSIQ score (95% CI = -50.9 to -15.0). When seizures were analyzed as a categorical variable, compared with infants without seizures, those with severe neonatal seizures had an average 29.7-point lower adjusted FSIQ score (95% CI = -45.2 to -14.2), and those with mild/moderate seizures had a 14.2-point lower FSIQ score (95% CI = -26.5 to -1.9). The adjusted impact of seizures on the WPPSI-R Performance and Verbal IQ scores was similar to that on the FSIQ score. The association between seizure severity and adverse cognitive outcome was not modified by the predominant pattern of injury (ie, basal nuclei vs watershed) or by the severity of the basal nuclei or watershed injury.
The association between neuromotor outcome and seizures also persisted after adjusting for the severity of injury as measured by MRI, with an odds ratio of a neuromotor score $ 2 of 20 (95% CI = 3 to 140) for children with neonatal seizures compared with those without seizures.
Sensitivity Analyses
We performed sensitivity analyses to examine the effect of death and timing of imaging on the results. To account for deaths in the data set, we imputed the lowest FSIQ score and a neuromotor score of 6 for those children who died before neurodevelopmental testing at age 4 years, and found that the magnitude of the effect of severe or mild/moderate seizures was similar, and the results remained highly significant.
Because imaging changes before the third day of life are best measured using diffusion-weighted imaging, 18 ,21 but this technique was not available for all infants in this study, we performed sensitivity analysis to restrict the results to the 52 infants who underwent imaging after this time. Again, we found a similar effect for severe and mild/moderate seizures; however, the P value was .06, reflecting the smaller sample size.
Discussion
Our data indicate that the association between clinical neonatal seizures treated in accordance with local standards of care and adverse long-term neurodevelopmental outcomes in infants with neonatal encephalopathy is independent of the severity of hypoxic-ischemic brain injury. After adjusting for the severity of hypoxic-ischemic brain injury as measured by MRI, infants with clinical seizures had dramatically worse WPPSI-R FSIQ scores at age 4 compared with those children without neonatal seizures. The effect varied with the severity of seizure; average adjusted FSIQ scores were 2 SDs lower in children with severe neonatal seizures and 1 SD lower in those with mild/moderate neonatal seizures. Our findings are supported by animal models demonstrating seizure damage in immature brains, especially in the setting of hypoxiaischemia. Rat pups exposed to hypoxia-ischemia and kainic acid-induced seizures had preferential injury to the hippocampus and high glutamate levels. 22, 23 Even healthy rat pups who suffered recurrent seizures were significantly worse than controls in terms of neurobehavioral tasks indicating impaired learning, memory, and activity level. [24] [25] [26] [27] The mechanisms behind these deficits are unknown, but may be related to reduced density of dendritic spines in hippocampal pyramidal neurons, 28 delayed neuronal loss, 29 decreased neurogenesis, 30 or changes in hippocampal plasticity, such as decreased capacity for long-term potentiation, reduced susceptibility to kindling, and enhanced paired-pulse inhibition. 25 Despite our robust results and blinded study design, a possible alternative explanation for the adjusted association between neonatal seizures and adverse outcome is residual confounding from unmeasured brain injury. In our adjusted analysis, we used validated scales to assess for the degree of both basal nuclei and watershed injury visible on T1-and T2-weighted MRI images. Unmeasured injuryfor example, to the hippocampus, which is difficult to image, yet important in both epileptogenesis and cognitive outcome-could account for both the seizures and the poor neurodevelopmental outcomes. Nonetheless, MRI is currently the best-known method for measuring the severity of brain injury after perinatal hypoxia-ischemia, and the basal nuclei and watershed scales are highly correlated with cognitive and neuromotor outcomes in this cohort. Furthermore, the effect of seizures remained unchanged in the sensitivity analyses, and the outcome was similar in all patterns of brain injury. Finally, the effect of the seizures themselves could not be differentiated from the effects of standard medical management using antiseizure medications such as phenbarbital and phenytoin, which exhibit neurotoxic effects in experimental animal models. 8 The present study used a large cohort, high-quality neuroimaging, and long-term outcomes to examine the impact of seizures on neurodevelopment in infants with hypoxic-ischemic brain injury. The data are limited by our ability to precisely measure the severity of seizures (particularly electrical seizures without clinical accompaniment) and to confirm that clinical seizures represent true electrographic seizures. EEG was normal in 11 of the 25 infants with clinical seizures, due possibly to several reasons. First, some newborns may have experienced clinical seizure types with inconsistent association to EEG findings (eg, motor automatisms, myoclonic seizures). Second, medication given before the EEG may have resulted in seizure resolution. Finally, the infants underwent routine screening EEG rather than long-term monitoring, making it likely that some seizures went undetected. (At the time of this study, our center had no standard protocol for the timing and duration of continuous EEG monitoring of infants at risk for seizures.) The seizure score reflects the number and refractoriness of seizures, as well as the degree of EEG abnormality. Past studies have shown that infants with seizures that respond to phenobarbital typically have a lower seizure burden and relatively normal EEG background, 31 making our categorization into 3 levels (ie, none, mild/moderate, and severe) clinically relevant. Our seizure measurements reflect the standard of care at our center at the time that this cohort was enrolled and the contemporary standard of care in most centers.
Using MRI as a sensitive measure of the degree of hypoxicischemic brain injury, we can now start to differentiate between the overlapping adverse effects of the hypoxicischemic brain injury and early seizures in human infants. Our finding that infants with clinical neonatal seizures in the setting of neonatal encephalopathy had worse longterm neurodevelopmental outcomes that were independent of the degree of hypoxic-ischemic brain injury is consistent with our previous observation that impaired brain metabolism in the setting of seizures (ie, high lactate and lower N-acetylaspartate levels) is independent of the degree of injury measured on MRI. 12 Understanding how seizures affect the developing brain has enormous therapeutic implications. Newborns in this cohort were treated for ''clinical'' seizures, reflecting contemporary practice at the time of enrollment. There is no good evidence, and thus no widely accepted clinical consensus, regarding the most appropriate therapy for seizures in newborns, especially in the case of electrographic seizures without clinical correlates and seizures identified by amplitude-integrated EEG. With the rapid increase in prolonged cortical monitoring methods, further studies are needed to determine the relative impact of seizures that are electrographic only, as well as to evaluate whether more aggressive treatment of seizures has a long-term beneficial neurodevelopmental effect.
Our data suggest that clinical neonatal seizures and their treatment are associated with adverse long-term cognitive and neuromotor outcomes in children at risk for perinatal asphyxia that are independent of sensitive MRI measures of hypoxic-ischemic injury. Having accounted for the severity of hypoxic-ischemic injury, the worsening neurodevelopmental outcomes with increasing seizure severity in our cohort is in keeping with the hypothesis that the seizures themselves may impair the developing human brain. Although our findings are consistent with previous experimental evidence, further work is needed, both in animal models and in humans, to identify the mechanisms through which seizures may impair the developing brain and to determine whether differences in seizure treatment can improve neurodevelopmental outcome. n 
